

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 7.26991361 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.26991361 |
| 3 | L-phenylalanine metabolic process (GO:0006558) | 6.94504695 |
| 4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.94504695 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.52323228 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.12060982 |
| 7 | bile acid biosynthetic process (GO:0006699) | 5.93917731 |
| 8 | indole-containing compound catabolic process (GO:0042436) | 5.92305238 |
| 9 | indolalkylamine catabolic process (GO:0046218) | 5.92305238 |
| 10 | tryptophan catabolic process (GO:0006569) | 5.92305238 |
| 11 | kynurenine metabolic process (GO:0070189) | 5.87717590 |
| 12 | alpha-linolenic acid metabolic process (GO:0036109) | 5.67542670 |
| 13 | angiotensin maturation (GO:0002003) | 5.59639974 |
| 14 | tryptophan metabolic process (GO:0006568) | 5.55786025 |
| 15 | desmosome organization (GO:0002934) | 5.47842727 |
| 16 | high-density lipoprotein particle remodeling (GO:0034375) | 5.46244958 |
| 17 | glyoxylate metabolic process (GO:0046487) | 5.44137823 |
| 18 | urea metabolic process (GO:0019627) | 5.38196568 |
| 19 | urea cycle (GO:0000050) | 5.38196568 |
| 20 | negative regulation of fibrinolysis (GO:0051918) | 5.32600436 |
| 21 | regulation of protein activation cascade (GO:2000257) | 5.25218681 |
| 22 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.21805939 |
| 23 | protein carboxylation (GO:0018214) | 5.21805939 |
| 24 | complement activation, alternative pathway (GO:0006957) | 5.21549710 |
| 25 | regulation of fibrinolysis (GO:0051917) | 5.18527519 |
| 26 | tyrosine metabolic process (GO:0006570) | 5.12550781 |
| 27 | sulfur amino acid catabolic process (GO:0000098) | 5.11111782 |
| 28 | cysteine metabolic process (GO:0006534) | 5.07353027 |
| 29 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.02117573 |
| 30 | nitrogen cycle metabolic process (GO:0071941) | 4.95487324 |
| 31 | regulation of complement activation (GO:0030449) | 4.95277717 |
| 32 | bile acid metabolic process (GO:0008206) | 4.94819829 |
| 33 | aromatic amino acid family metabolic process (GO:0009072) | 4.90810027 |
| 34 | phospholipid efflux (GO:0033700) | 4.88567568 |
| 35 | reverse cholesterol transport (GO:0043691) | 4.77151606 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.76533559 |
| 37 | serine family amino acid catabolic process (GO:0009071) | 4.76491208 |
| 38 | regulation of cholesterol esterification (GO:0010872) | 4.72868220 |
| 39 | positive regulation of respiratory burst (GO:0060267) | 4.71464813 |
| 40 | plasma lipoprotein particle remodeling (GO:0034369) | 4.69504534 |
| 41 | protein-lipid complex remodeling (GO:0034368) | 4.69504534 |
| 42 | macromolecular complex remodeling (GO:0034367) | 4.69504534 |
| 43 | positive regulation of pseudopodium assembly (GO:0031274) | 4.61697029 |
| 44 | amino-acid betaine metabolic process (GO:0006577) | 4.54861875 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.50775723 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.50775723 |
| 47 | regulation of cellular extravasation (GO:0002691) | 4.47039508 |
| 48 | negative regulation of sterol transport (GO:0032372) | 4.45519577 |
| 49 | negative regulation of cholesterol transport (GO:0032375) | 4.45519577 |
| 50 | coenzyme catabolic process (GO:0009109) | 4.44747956 |
| 51 | homocysteine metabolic process (GO:0050667) | 4.43723491 |
| 52 | alpha-amino acid catabolic process (GO:1901606) | 4.37849582 |
| 53 | lysine catabolic process (GO:0006554) | 4.35755969 |
| 54 | lysine metabolic process (GO:0006553) | 4.35755969 |
| 55 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 4.35079987 |
| 56 | glomerular filtration (GO:0003094) | 4.34325254 |
| 57 | bile acid and bile salt transport (GO:0015721) | 4.32171119 |
| 58 | renal filtration (GO:0097205) | 4.30388913 |
| 59 | cellular ketone body metabolic process (GO:0046950) | 4.27861831 |
| 60 | benzene-containing compound metabolic process (GO:0042537) | 4.24809228 |
| 61 | imidazole-containing compound metabolic process (GO:0052803) | 4.21200396 |
| 62 | plasma lipoprotein particle clearance (GO:0034381) | 4.18684150 |
| 63 | fibrinolysis (GO:0042730) | 4.14951261 |
| 64 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 4.14866383 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 4.14708307 |
| 66 | cholesterol efflux (GO:0033344) | 4.12986909 |
| 67 | regulation of pseudopodium assembly (GO:0031272) | 4.11963774 |
| 68 | cellular glucuronidation (GO:0052695) | 4.07131275 |
| 69 | amine catabolic process (GO:0009310) | 4.07110918 |
| 70 | cellular biogenic amine catabolic process (GO:0042402) | 4.07110918 |
| 71 | glycine metabolic process (GO:0006544) | 4.04220866 |
| 72 | low-density lipoprotein particle remodeling (GO:0034374) | 4.03072720 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 4.02207253 |
| 74 | glutamate metabolic process (GO:0006536) | 4.00272388 |
| 75 | adhesion of symbiont to host cell (GO:0044650) | 3.97566232 |
| 76 | virion attachment to host cell (GO:0019062) | 3.97566232 |
| 77 | ethanol oxidation (GO:0006069) | 3.97036611 |
| 78 | cellular modified amino acid catabolic process (GO:0042219) | 3.96753869 |
| 79 | vitamin A metabolic process (GO:0006776) | 3.88215138 |
| 80 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.86020763 |
| 81 | serine family amino acid metabolic process (GO:0009069) | 3.85250658 |
| 82 | regulation of guanylate cyclase activity (GO:0031282) | 3.85059554 |
| 83 | antimicrobial humoral response (GO:0019730) | 3.83216029 |
| 84 | antibacterial humoral response (GO:0019731) | 3.82489541 |
| 85 | plasma lipoprotein particle assembly (GO:0034377) | 3.81229723 |
| 86 | hemidesmosome assembly (GO:0031581) | 3.80815285 |
| 87 | arginine metabolic process (GO:0006525) | 3.78688980 |
| 88 | negative regulation of lipase activity (GO:0060192) | 3.77107090 |
| 89 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.76991270 |
| 90 | aldehyde catabolic process (GO:0046185) | 3.76578186 |
| 91 | complement activation, classical pathway (GO:0006958) | 3.74749883 |
| 92 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 3.74397316 |
| 93 | cofactor catabolic process (GO:0051187) | 3.71150191 |
| 94 | cytolysis (GO:0019835) | 3.70389385 |
| 95 | regulation of respiratory burst (GO:0060263) | 3.70215338 |
| 96 | regulation of cholesterol homeostasis (GO:2000188) | 3.69925716 |
| 97 | ketone body metabolic process (GO:1902224) | 3.69890884 |
| 98 | complement activation (GO:0006956) | 3.69167092 |
| 99 | positive regulation of lipid catabolic process (GO:0050996) | 3.68855993 |
| 100 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.67200673 |
| 101 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.67200673 |
| 102 | uronic acid metabolic process (GO:0006063) | 3.65361379 |
| 103 | glucuronate metabolic process (GO:0019585) | 3.65361379 |
| 104 | intestinal absorption (GO:0050892) | 3.64829496 |
| 105 | blood coagulation, intrinsic pathway (GO:0007597) | 3.64796292 |
| 106 | protein activation cascade (GO:0072376) | 3.62279824 |
| 107 | acetyl-CoA metabolic process (GO:0006084) | 3.62101870 |
| 108 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.62001668 |
| 109 | linoleic acid metabolic process (GO:0043651) | 3.58746524 |
| 110 | carboxylic acid catabolic process (GO:0046395) | 3.56833137 |
| 111 | organic acid catabolic process (GO:0016054) | 3.56833137 |
| 112 | cholesterol homeostasis (GO:0042632) | 3.56171947 |
| 113 | plasma lipoprotein particle organization (GO:0071827) | 3.54496057 |
| 114 | very long-chain fatty acid metabolic process (GO:0000038) | 3.53610053 |
| 115 | serine family amino acid biosynthetic process (GO:0009070) | 3.53143971 |
| 116 | alkaloid metabolic process (GO:0009820) | 3.52572123 |
| 117 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.51786255 |
| 118 | sterol homeostasis (GO:0055092) | 3.49450612 |
| 119 | phospholipid homeostasis (GO:0055091) | 3.49342569 |
| 120 | regulation of bile acid biosynthetic process (GO:0070857) | 3.45860689 |
| 121 | negative regulation of protein activation cascade (GO:2000258) | 3.45817255 |
| 122 | drug catabolic process (GO:0042737) | 3.44856922 |
| 123 | adhesion of symbiont to host (GO:0044406) | 3.43243415 |
| 124 | regulation of vitamin metabolic process (GO:0030656) | 3.30648625 |
| 125 | NADH metabolic process (GO:0006734) | 3.25884983 |
| 126 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.22826459 |
| 127 | peptide catabolic process (GO:0043171) | 3.18442420 |
| 128 | cyclooxygenase pathway (GO:0019371) | 3.14993318 |
| 129 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.11515182 |
| 130 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.04164055 |
| 131 | regulation of extracellular matrix disassembly (GO:0010715) | 3.03525139 |
| 132 | eosinophil chemotaxis (GO:0048245) | 3.01688153 |
| 133 | glycosphingolipid catabolic process (GO:0046479) | 3.00625166 |
| 134 | O-glycan processing (GO:0016266) | 2.93520116 |
| 135 | glycolipid catabolic process (GO:0019377) | 2.91845333 |
| 136 | vitamin transmembrane transport (GO:0035461) | 2.89013018 |
| 137 | positive regulation of guanylate cyclase activity (GO:0031284) | 2.85616102 |
| 138 | diterpenoid biosynthetic process (GO:0016102) | 2.81887159 |
| 139 | barbed-end actin filament capping (GO:0051016) | 2.77959758 |
| 140 | multicellular organismal water homeostasis (GO:0050891) | 2.77502390 |
| 141 | regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 2.77422656 |
| 142 | endocrine process (GO:0050886) | 2.77422656 |
| 143 | regulation of systemic arterial blood pressure by hormone (GO:0001990) | 2.77422656 |
| 144 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.71397446 |
| 145 | regulation of keratinocyte proliferation (GO:0010837) | 2.71106097 |
| 146 | basement membrane organization (GO:0071711) | 2.69845244 |
| 147 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.68310346 |
| 148 | epithelial cell-cell adhesion (GO:0090136) | 2.68163561 |
| 149 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 2.66430585 |
| 150 | fructose metabolic process (GO:0006000) | 2.66368865 |
| 151 | eosinophil migration (GO:0072677) | 2.64597616 |
| 152 | oligosaccharide biosynthetic process (GO:0009312) | 2.64241431 |
| 153 | regulation of apoptotic cell clearance (GO:2000425) | 2.61959105 |
| 154 | regulation of water loss via skin (GO:0033561) | 2.61597818 |
| 155 | branching involved in mammary gland duct morphogenesis (GO:0060444) | 2.57525628 |
| 156 | regulation of systemic arterial blood pressure (GO:0003073) | 2.55411403 |
| 157 | primary alcohol catabolic process (GO:0034310) | 2.54767845 |
| 158 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.54377522 |
| 159 | regulation of cGMP biosynthetic process (GO:0030826) | 2.54371732 |
| 160 | multicellular organismal catabolic process (GO:0044243) | 2.53073323 |
| 161 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.52114604 |
| 162 | keratan sulfate catabolic process (GO:0042340) | 2.51274492 |
| 163 | regulation of transforming growth factor beta1 production (GO:0032908) | 2.51021343 |
| 164 | transcytosis (GO:0045056) | 2.47571420 |
| 165 | chronic inflammatory response (GO:0002544) | 2.47045983 |
| 166 | surfactant homeostasis (GO:0043129) | 2.46940032 |
| 167 | regulation of necrotic cell death (GO:0010939) | 2.46761470 |
| 168 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.45272488 |
| 169 | peptide hormone processing (GO:0016486) | 2.43243922 |
| 170 | sexual reproduction (GO:0019953) | 2.43202547 |
| 171 | Golgi transport vesicle coating (GO:0048200) | 2.42590099 |
| 172 | COPI coating of Golgi vesicle (GO:0048205) | 2.42590099 |
| 173 | epithelial structure maintenance (GO:0010669) | 2.39997181 |
| 174 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.39113780 |
| 175 | GDP-mannose metabolic process (GO:0019673) | 2.38940132 |
| 176 | lipoprotein transport (GO:0042953) | 2.38901087 |
| 177 | multicellular organismal metabolic process (GO:0044236) | 2.35602087 |
| 178 | ethanol metabolic process (GO:0006067) | 2.34252623 |
| 179 | establishment of skin barrier (GO:0061436) | 2.31353430 |
| 180 | humoral immune response (GO:0006959) | 2.31019915 |
| 181 | water homeostasis (GO:0030104) | 2.30733398 |
| 182 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.30709415 |
| 183 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 2.30282984 |
| 184 | sphingomyelin metabolic process (GO:0006684) | 2.30004846 |
| 185 | ceramide catabolic process (GO:0046514) | 2.29535654 |
| 186 | epoxygenase P450 pathway (GO:0019373) | 2.29052875 |
| 187 | hormone catabolic process (GO:0042447) | 2.28868172 |
| 188 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 2.28630628 |
| 189 | fibril organization (GO:0097435) | 2.27832091 |
| 190 | negative regulation of keratinocyte proliferation (GO:0010839) | 2.27585950 |
| 191 | citrulline biosynthetic process (GO:0019240) | 2.27329415 |
| 192 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.27204507 |
| 193 | phosphatidylserine acyl-chain remodeling (GO:0036150) | 2.27027881 |
| 194 | negative regulation of leukocyte migration (GO:0002686) | 2.26954108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 7.59392764 |
| 2 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.55928155 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.27665527 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.81839808 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.90068667 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.69891187 |
| 7 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.34469346 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.64885728 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.17036169 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.34550129 |
| 11 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.22819404 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.14838514 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 10.8193080 |
| 14 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.97651882 |
| 15 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.80417663 |
| 16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.79308812 |
| 17 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.78420760 |
| 18 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.74069080 |
| 19 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.69616912 |
| 20 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.68364655 |
| 21 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.56602549 |
| 22 | GATA1_22025678_ChIP-Seq_K562_Human | 1.55376470 |
| 23 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.54305480 |
| 24 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.52254685 |
| 25 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.47199288 |
| 26 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.41559622 |
| 27 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.40445034 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.37538261 |
| 29 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.37071293 |
| 30 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.36393241 |
| 31 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.36393241 |
| 32 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.35654003 |
| 33 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.34195701 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.33931682 |
| 35 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.30597660 |
| 36 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.29698395 |
| 37 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.29597339 |
| 38 | KLF5_25053715_ChIP-Seq_YYC3_Human | 1.29229125 |
| 39 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.29146872 |
| 40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.24112563 |
| 41 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.22766428 |
| 42 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.20559577 |
| 43 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.19239732 |
| 44 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.18197315 |
| 45 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17818224 |
| 46 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.13396039 |
| 47 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.11594697 |
| 48 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.11317944 |
| 49 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.08796244 |
| 50 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.08403657 |
| 51 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.08399676 |
| 52 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.08046259 |
| 53 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.06474533 |
| 54 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.06278664 |
| 55 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.04840309 |
| 56 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01954995 |
| 57 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01954995 |
| 58 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.96577261 |
| 59 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94912694 |
| 60 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.93927411 |
| 61 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.92652543 |
| 62 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.92648421 |
| 63 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.92123647 |
| 64 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.91928104 |
| 65 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.89293000 |
| 66 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89048141 |
| 67 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.88978006 |
| 68 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.88457962 |
| 69 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88423421 |
| 70 | ATF3_27146783_Chip-Seq_COLON_Human | 0.88314958 |
| 71 | GATA1_19941826_ChIP-Seq_K562_Human | 0.86662254 |
| 72 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86445781 |
| 73 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86280582 |
| 74 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.86134115 |
| 75 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.85344993 |
| 76 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.85297212 |
| 77 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.83573388 |
| 78 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.83319615 |
| 79 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.81990601 |
| 80 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.81990601 |
| 81 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.80217969 |
| 82 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.78968910 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78370283 |
| 84 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.77254609 |
| 85 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.76411088 |
| 86 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.76039959 |
| 87 | * BCAT_22108803_ChIP-Seq_LS180_Human | 0.72484372 |
| 88 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.72267241 |
| 89 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.72040148 |
| 90 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.69483347 |
| 91 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69329144 |
| 92 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.69126882 |
| 93 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.69074136 |
| 94 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.69034267 |
| 95 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.68534281 |
| 96 | * SOX2_20726797_ChIP-Seq_SW620_Human | 0.68506693 |
| 97 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.67944552 |
| 98 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.67333751 |
| 99 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.66338908 |
| 100 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65849278 |
| 101 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.65219525 |
| 102 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.63877569 |
| 103 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.63253137 |
| 104 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60769620 |
| 105 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.60544189 |
| 106 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.60030907 |
| 107 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.59886503 |
| 108 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.59149997 |
| 109 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.58892111 |
| 110 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.58584968 |
| 111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.58029467 |
| 112 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.57707275 |
| 113 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.57623941 |
| 114 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.57328560 |
| 115 | AR_20517297_ChIP-Seq_VCAP_Human | 0.55525164 |
| 116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.55086228 |
| 117 | * KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.54862858 |
| 118 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.54336057 |
| 119 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.53809119 |
| 120 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.53306381 |
| 121 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.53078321 |
| 122 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.52815257 |
| 123 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.50478976 |
| 124 | CBP_21632823_ChIP-Seq_H3396_Human | 0.50403590 |
| 125 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.49875508 |
| 126 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.49589301 |
| 127 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.49164206 |
| 128 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.48585603 |
| 129 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.48543754 |
| 130 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.48194944 |
| 131 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.46691522 |
| 132 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.46338144 |
| 133 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.45622671 |
| 134 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.45113503 |
| 135 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.44783168 |
| 136 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.44697978 |
| 137 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.44646377 |
| 138 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.44224752 |
| 139 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.44081818 |
| 140 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.43189140 |
| 141 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.43088839 |
| 142 | GATA2_19941826_ChIP-Seq_K562_Human | 0.43023468 |
| 143 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.43021672 |
| 144 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.42658818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.93881824 |
| 2 | MP0005360_urolithiasis | 7.07199019 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.27501682 |
| 4 | MP0005365_abnormal_bile_salt | 5.89460922 |
| 5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.69429477 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.05714698 |
| 7 | MP0003252_abnormal_bile_duct | 3.69674160 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.41720564 |
| 9 | MP0005083_abnormal_biliary_tract | 3.25326263 |
| 10 | MP0009840_abnormal_foam_cell | 3.13180713 |
| 11 | MP0008438_abnormal_cutaneous_collagen | 3.07660966 |
| 12 | MP0010352_gastrointestinal_tract_polyps | 2.88376824 |
| 13 | MP0010155_abnormal_intestine_physiology | 2.63800665 |
| 14 | MP0003195_calcinosis | 2.55149310 |
| 15 | MP0005332_abnormal_amino_acid | 2.53792776 |
| 16 | MP0001666_abnormal_nutrient_absorption | 2.51288994 |
| 17 | MP0003191_abnormal_cellular_cholesterol | 2.43174750 |
| 18 | MP0004264_abnormal_extraembryonic_tissu | 2.40773967 |
| 19 | MP0004858_abnormal_nervous_system | 2.32178013 |
| 20 | MP0005451_abnormal_body_composition | 2.20371336 |
| 21 | MP0002796_impaired_skin_barrier | 2.19627938 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.02517459 |
| 23 | MP0004019_abnormal_vitamin_homeostasis | 2.00338255 |
| 24 | MP0003724_increased_susceptibility_to | 1.99632460 |
| 25 | MP0000609_abnormal_liver_physiology | 1.98220097 |
| 26 | MP0003183_abnormal_peptide_metabolism | 1.93840662 |
| 27 | MP0005058_abnormal_lysosome_morphology | 1.89484368 |
| 28 | MP0005023_abnormal_wound_healing | 1.81223586 |
| 29 | MP0003868_abnormal_feces_composition | 1.78918230 |
| 30 | MP0008004_abnormal_stomach_pH | 1.74568827 |
| 31 | MP0005409_darkened_coat_color | 1.70447037 |
| 32 | MP0002138_abnormal_hepatobiliary_system | 1.65532857 |
| 33 | MP0005319_abnormal_enzyme/_coenzyme | 1.63990009 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.63832589 |
| 35 | MP0009697_abnormal_copulation | 1.63321981 |
| 36 | MP0005257_abnormal_intraocular_pressure | 1.62802962 |
| 37 | MP0003279_aneurysm | 1.62759257 |
| 38 | MP0003011_delayed_dark_adaptation | 1.60640269 |
| 39 | MP0004272_abnormal_basement_membrane | 1.57851163 |
| 40 | MP0002254_reproductive_system_inflammat | 1.54112931 |
| 41 | MP0003866_abnormal_defecation | 1.52844983 |
| 42 | MP0000678_abnormal_parathyroid_gland | 1.51762116 |
| 43 | MP0000566_synostosis | 1.51456006 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.50996436 |
| 45 | MP0003303_peritoneal_inflammation | 1.49861134 |
| 46 | MP0005503_abnormal_tendon_morphology | 1.42848103 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.42751490 |
| 48 | MP0009785_altered_susceptibility_to | 1.40088442 |
| 49 | MP0001849_ear_inflammation | 1.39855150 |
| 50 | MP0003566_abnormal_cell_adhesion | 1.39411585 |
| 51 | MP0003448_altered_tumor_morphology | 1.39375137 |
| 52 | MP0010234_abnormal_vibrissa_follicle | 1.36611632 |
| 53 | MP0001764_abnormal_homeostasis | 1.35358569 |
| 54 | MP0001664_abnormal_digestion | 1.35315091 |
| 55 | MP0001533_abnormal_skeleton_physiology | 1.31571957 |
| 56 | MP0002896_abnormal_bone_mineralization | 1.31035240 |
| 57 | MP0010678_abnormal_skin_adnexa | 1.30210474 |
| 58 | MP0001790_abnormal_immune_system | 1.29505880 |
| 59 | MP0005387_immune_system_phenotype | 1.29505880 |
| 60 | MP0005647_abnormal_sex_gland | 1.28729200 |
| 61 | MP0003045_fibrosis | 1.26557650 |
| 62 | MP0000537_abnormal_urethra_morphology | 1.25103571 |
| 63 | MP0001958_emphysema | 1.22476623 |
| 64 | MP0000477_abnormal_intestine_morphology | 1.21984849 |
| 65 | MP0004381_abnormal_hair_follicle | 1.21531358 |
| 66 | MP0005275_abnormal_skin_tensile | 1.20804770 |
| 67 | MP0000604_amyloidosis | 1.20430844 |
| 68 | MP0006082_CNS_inflammation | 1.19390892 |
| 69 | MP0000579_abnormal_nail_morphology | 1.18198759 |
| 70 | MP0003656_abnormal_erythrocyte_physiolo | 1.15646986 |
| 71 | MP0005165_increased_susceptibility_to | 1.15244507 |
| 72 | MP0003091_abnormal_cell_migration | 1.15066671 |
| 73 | MP0001873_stomach_inflammation | 1.14899941 |
| 74 | MP0009643_abnormal_urine_homeostasis | 1.10542822 |
| 75 | MP0003186_abnormal_redox_activity | 1.09829028 |
| 76 | MP0002998_abnormal_bone_remodeling | 1.09144954 |
| 77 | MP0002148_abnormal_hypersensitivity_rea | 1.08947334 |
| 78 | MP0000858_altered_metastatic_potential | 1.08405937 |
| 79 | MP0005164_abnormal_response_to | 1.07831681 |
| 80 | MP0005025_abnormal_response_to | 1.07052108 |
| 81 | MP0005501_abnormal_skin_physiology | 1.06085315 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.01451747 |
| 83 | MP0000249_abnormal_blood_vessel | 1.01183754 |
| 84 | MP0009764_decreased_sensitivity_to | 0.97782407 |
| 85 | MP0006054_spinal_hemorrhage | 0.97264776 |
| 86 | MP0002060_abnormal_skin_morphology | 0.96237103 |
| 87 | MP0000598_abnormal_liver_morphology | 0.96099912 |
| 88 | MP0001663_abnormal_digestive_system | 0.96003417 |
| 89 | MP0003329_amyloid_beta_deposits | 0.95979200 |
| 90 | MP0000490_abnormal_crypts_of | 0.93741967 |
| 91 | MP0000343_altered_response_to | 0.90172285 |
| 92 | MP0001835_abnormal_antigen_presentation | 0.90144694 |
| 93 | MP0005390_skeleton_phenotype | 0.89287442 |
| 94 | MP0000462_abnormal_digestive_system | 0.87642537 |
| 95 | MP0000427_abnormal_hair_cycle | 0.86812706 |
| 96 | MP0005381_digestive/alimentary_phenotyp | 0.84825513 |
| 97 | MP0001765_abnormal_ion_homeostasis | 0.83884851 |
| 98 | MP0002876_abnormal_thyroid_physiology | 0.83794255 |
| 99 | MP0009763_increased_sensitivity_to | 0.83224396 |
| 100 | MP0005310_abnormal_salivary_gland | 0.81310599 |
| 101 | MP0000383_abnormal_hair_follicle | 0.80368170 |
| 102 | MP0000685_abnormal_immune_system | 0.80250622 |
| 103 | MP0008260_abnormal_autophagy | 0.80148238 |
| 104 | MP0005636_abnormal_mineral_homeostasis | 0.79064627 |
| 105 | MP0000465_gastrointestinal_hemorrhage | 0.78694946 |
| 106 | MP0000627_abnormal_mammary_gland | 0.78479491 |
| 107 | MP0001881_abnormal_mammary_gland | 0.77147402 |
| 108 | MP0002166_altered_tumor_susceptibility | 0.76359290 |
| 109 | MP0009642_abnormal_blood_homeostasis | 0.75449791 |
| 110 | MP0008469_abnormal_protein_level | 0.72860313 |
| 111 | MP0002933_joint_inflammation | 0.72776579 |
| 112 | MP0010368_abnormal_lymphatic_system | 0.72617375 |
| 113 | MP0001216_abnormal_epidermal_layer | 0.71063127 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.70090154 |
| 115 | MP0005408_hypopigmentation | 0.70064043 |
| 116 | MP0005670_abnormal_white_adipose | 0.69792834 |
| 117 | MP0010771_integument_phenotype | 0.69248669 |
| 118 | MP0004947_skin_inflammation | 0.68820073 |
| 119 | MP0009053_abnormal_anal_canal | 0.68420843 |
| 120 | MP0005334_abnormal_fat_pad | 0.65539409 |
| 121 | MP0002078_abnormal_glucose_homeostasis | 0.64925296 |
| 122 | MP0009765_abnormal_xenobiotic_induced | 0.64806270 |
| 123 | MP0001661_extended_life_span | 0.64335260 |
| 124 | MP0006036_abnormal_mitochondrial_physio | 0.63949245 |
| 125 | MP0002971_abnormal_brown_adipose | 0.63891524 |
| 126 | MP0000647_abnormal_sebaceous_gland | 0.61622364 |
| 127 | MP0005535_abnormal_body_temperature | 0.60456768 |
| 128 | MP0005376_homeostasis/metabolism_phenot | 0.60066346 |
| 129 | MP0005220_abnormal_exocrine_pancreas | 0.59165281 |
| 130 | MP0004130_abnormal_muscle_cell | 0.57791429 |
| 131 | MP0005084_abnormal_gallbladder_morpholo | 0.57695708 |
| 132 | MP0001243_abnormal_dermal_layer | 0.57693509 |
| 133 | MP0004782_abnormal_surfactant_physiolog | 0.57491766 |
| 134 | MP0001756_abnormal_urination | 0.55075736 |
| 135 | MP0003690_abnormal_glial_cell | 0.54964890 |
| 136 | MP0000377_abnormal_hair_follicle | 0.52874372 |
| 137 | MP0009384_cardiac_valve_regurgitation | 0.52262440 |
| 138 | MP0003638_abnormal_response/metabolism_ | 0.50448648 |
| 139 | MP0006035_abnormal_mitochondrial_morpho | 0.50312169 |
| 140 | MP0008874_decreased_physiological_sensi | 0.50177241 |
| 141 | MP0000639_abnormal_adrenal_gland | 0.49155637 |
| 142 | MP0005448_abnormal_energy_balance | 0.48015370 |
| 143 | MP0002098_abnormal_vibrissa_morphology | 0.47698168 |
| 144 | MP0009931_abnormal_skin_appearance | 0.45379622 |
| 145 | MP0005266_abnormal_metabolism | 0.44449373 |
| 146 | MP0002837_dystrophic_cardiac_calcinosis | 0.41340094 |
| 147 | MP0002136_abnormal_kidney_physiology | 0.40635833 |
| 148 | MP0005666_abnormal_adipose_tissue | 0.38475119 |
| 149 | MP0002928_abnormal_bile_duct | 0.37886386 |
| 150 | MP0000230_abnormal_systemic_arterial | 0.37087141 |
| 151 | MP0002735_abnormal_chemical_nociception | 0.36978469 |
| 152 | MP0005464_abnormal_platelet_physiology | 0.35655570 |
| 153 | MP0003436_decreased_susceptibility_to | 0.35276539 |
| 154 | MP0000467_abnormal_esophagus_morphology | 0.34918409 |
| 155 | MP0005166_decreased_susceptibility_to | 0.34206967 |
| 156 | MP0005395_other_phenotype | 0.34162965 |
| 157 | MP0000367_abnormal_coat/_hair | 0.34160325 |
| 158 | MP0001191_abnormal_skin_condition | 0.33892236 |
| 159 | MP0009379_abnormal_foot_pigmentation | 0.32228326 |
| 160 | MP0003953_abnormal_hormone_level | 0.31113513 |
| 161 | MP0000538_abnormal_urinary_bladder | 0.31004692 |
| 162 | MP0004185_abnormal_adipocyte_glucose | 0.30686030 |
| 163 | MP0003075_altered_response_to | 0.30404383 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.30542791 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.15744377 |
| 3 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.07009766 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.44667171 |
| 5 | Xanthomatosis (HP:0000991) | 6.32470980 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.26383002 |
| 7 | Hypobetalipoproteinemia (HP:0003563) | 6.17131171 |
| 8 | Complement deficiency (HP:0004431) | 5.42265472 |
| 9 | Hyperlipoproteinemia (HP:0010980) | 5.41458906 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.67425573 |
| 11 | Epidermoid cyst (HP:0200040) | 4.59526354 |
| 12 | Joint hemorrhage (HP:0005261) | 4.41228790 |
| 13 | Hyperammonemia (HP:0001987) | 4.32821667 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.23453953 |
| 15 | Abnormality of the common coagulation pathway (HP:0010990) | 4.22092726 |
| 16 | Hypoalphalipoproteinemia (HP:0003233) | 4.14358435 |
| 17 | Fat malabsorption (HP:0002630) | 4.11321940 |
| 18 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.09020629 |
| 19 | Hyperglycinemia (HP:0002154) | 4.08296227 |
| 20 | Abnormality of complement system (HP:0005339) | 4.03440426 |
| 21 | Abnormality of methionine metabolism (HP:0010901) | 4.02765349 |
| 22 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.96726679 |
| 23 | Ketosis (HP:0001946) | 3.91838706 |
| 24 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.91373226 |
| 25 | Hyperglycinuria (HP:0003108) | 3.68594189 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.63437589 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.63437589 |
| 28 | Pili torti (HP:0003777) | 3.61570925 |
| 29 | Hypoglycemic coma (HP:0001325) | 3.60330164 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.56905152 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.50028333 |
| 32 | Alopecia of scalp (HP:0002293) | 3.47877956 |
| 33 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.41881917 |
| 34 | Hypercholesterolemia (HP:0003124) | 3.40872627 |
| 35 | Atrophic scars (HP:0001075) | 3.24357537 |
| 36 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.19159266 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.15775866 |
| 38 | Steatorrhea (HP:0002570) | 3.15724522 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.11379163 |
| 40 | Premature rupture of membranes (HP:0001788) | 2.88970893 |
| 41 | Delayed CNS myelination (HP:0002188) | 2.82795169 |
| 42 | Ketoacidosis (HP:0001993) | 2.80388921 |
| 43 | Abnormality of the nasal mucosa (HP:0000433) | 2.79950826 |
| 44 | Recurrent bronchitis (HP:0002837) | 2.79216803 |
| 45 | Abnormality of nucleobase metabolism (HP:0010932) | 2.77618457 |
| 46 | Myocardial infarction (HP:0001658) | 2.77570330 |
| 47 | Abnormality of serum amino acid levels (HP:0003112) | 2.75361240 |
| 48 | Hyperactive renin-angiotensin system (HP:0000841) | 2.71992987 |
| 49 | Systemic lupus erythematosus (HP:0002725) | 2.71804833 |
| 50 | Spontaneous abortion (HP:0005268) | 2.70874271 |
| 51 | Abnormal hair laboratory examination (HP:0003328) | 2.70627132 |
| 52 | Cerebral aneurysm (HP:0004944) | 2.68939239 |
| 53 | Cervical subluxation (HP:0003308) | 2.68457595 |
| 54 | Neonatal onset (HP:0003623) | 2.66843372 |
| 55 | Skin nodule (HP:0200036) | 2.62999553 |
| 56 | Focal segmental glomerulosclerosis (HP:0000097) | 2.61639740 |
| 57 | Hepatocellular carcinoma (HP:0001402) | 2.59534206 |
| 58 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.58105937 |
| 59 | Osteolytic defects of the hand bones (HP:0009699) | 2.58105937 |
| 60 | Abnormal gallbladder physiology (HP:0012438) | 2.56261391 |
| 61 | Cholecystitis (HP:0001082) | 2.56261391 |
| 62 | Vascular calcification (HP:0004934) | 2.53195632 |
| 63 | Hypochromic microcytic anemia (HP:0004840) | 2.52983933 |
| 64 | Aortic dissection (HP:0002647) | 2.51854556 |
| 65 | Metabolic acidosis (HP:0001942) | 2.51060179 |
| 66 | Mitral stenosis (HP:0001718) | 2.50200601 |
| 67 | Chronic sinusitis (HP:0011109) | 2.48979136 |
| 68 | Abnormal gallbladder morphology (HP:0012437) | 2.48373315 |
| 69 | Flattened epiphyses (HP:0003071) | 2.45959892 |
| 70 | Abnormality of purine metabolism (HP:0004352) | 2.45486727 |
| 71 | Hyperparathyroidism (HP:0000843) | 2.45417464 |
| 72 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.43037472 |
| 73 | Dicarboxylic aciduria (HP:0003215) | 2.43037472 |
| 74 | Malnutrition (HP:0004395) | 2.42589855 |
| 75 | Cholelithiasis (HP:0001081) | 2.42345494 |
| 76 | Chronic diarrhea (HP:0002028) | 2.42201441 |
| 77 | Nasal polyposis (HP:0100582) | 2.40559203 |
| 78 | Lethargy (HP:0001254) | 2.39461014 |
| 79 | Pulmonary artery stenosis (HP:0004415) | 2.37826961 |
| 80 | Amyloidosis (HP:0011034) | 2.35871271 |
| 81 | Eczematoid dermatitis (HP:0000976) | 2.34650838 |
| 82 | Thin bony cortex (HP:0002753) | 2.34449225 |
| 83 | Glomerulonephritis (HP:0000099) | 2.30852216 |
| 84 | Abnormality of glycolipid metabolism (HP:0010969) | 2.29735640 |
| 85 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.29735640 |
| 86 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.29735640 |
| 87 | Acanthocytosis (HP:0001927) | 2.28657127 |
| 88 | Chondrocalcinosis (HP:0000934) | 2.28539681 |
| 89 | Cardiovascular calcification (HP:0011915) | 2.27658629 |
| 90 | Ileus (HP:0002595) | 2.25903293 |
| 91 | Cerebral edema (HP:0002181) | 2.25145734 |
| 92 | Glomerulosclerosis (HP:0000096) | 2.24050214 |
| 93 | Axonal loss (HP:0003447) | 2.23766170 |
| 94 | Protrusio acetabuli (HP:0003179) | 2.21734174 |
| 95 | Interstitial pulmonary disease (HP:0006530) | 2.21052845 |
| 96 | Abnormality of Sharpey fibers (HP:0100685) | 2.20621030 |
| 97 | Irritability (HP:0000737) | 2.20128056 |
| 98 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.19834609 |
| 99 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.19306756 |
| 100 | Milia (HP:0001056) | 2.17593537 |
| 101 | Abnormality of proline metabolism (HP:0010907) | 2.17157985 |
| 102 | Hydroxyprolinuria (HP:0003080) | 2.17157985 |
| 103 | Gout (HP:0001997) | 2.16743306 |
| 104 | Hypoglycemic seizures (HP:0002173) | 2.15740927 |
| 105 | Sensorimotor neuropathy (HP:0007141) | 2.15699375 |
| 106 | Spastic diplegia (HP:0001264) | 2.15627312 |
| 107 | Dysostosis multiplex (HP:0000943) | 2.15569074 |
| 108 | Bronchitis (HP:0012387) | 2.15459772 |
| 109 | Late onset (HP:0003584) | 2.15248221 |
| 110 | Fragile skin (HP:0001030) | 2.15150224 |
| 111 | Aneurysm (HP:0002617) | 2.13979905 |
| 112 | Distal lower limb amyotrophy (HP:0008944) | 2.09890728 |
| 113 | Upper limb amyotrophy (HP:0009129) | 2.08749697 |
| 114 | Distal upper limb amyotrophy (HP:0007149) | 2.08749697 |
| 115 | Brushfield spots (HP:0001088) | 2.04327678 |
| 116 | Pigmentary retinal degeneration (HP:0001146) | 2.03887448 |
| 117 | Plantar hyperkeratosis (HP:0007556) | 2.03222655 |
| 118 | Abnormality of the Achilles tendon (HP:0005109) | 2.02597057 |
| 119 | Abnormality of the gallbladder (HP:0005264) | 2.02302837 |
| 120 | Vascular tortuosity (HP:0004948) | 2.01776753 |
| 121 | Arterial tortuosity (HP:0005116) | 2.01428494 |
| 122 | Bone cyst (HP:0012062) | 2.01305656 |
| 123 | Aortic aneurysm (HP:0004942) | 2.01132117 |
| 124 | Mucopolysacchariduria (HP:0008155) | 1.99769939 |
| 125 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.99769939 |
| 126 | Abdominal distention (HP:0003270) | 1.99045002 |
| 127 | Pancreatitis (HP:0001733) | 1.99031326 |
| 128 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.98583680 |
| 129 | Congenital sensorineural hearing impairment (HP:0008527) | 1.97877615 |
| 130 | Rickets (HP:0002748) | 1.96737187 |
| 131 | Hypotrichosis (HP:0001006) | 1.96656744 |
| 132 | Vertebral compression fractures (HP:0002953) | 1.95821825 |
| 133 | Opisthotonus (HP:0002179) | 1.93784385 |
| 134 | Vacuolated lymphocytes (HP:0001922) | 1.93317613 |
| 135 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.92907915 |
| 136 | Vomiting (HP:0002013) | 1.92519805 |
| 137 | Menorrhagia (HP:0000132) | 1.91853834 |
| 138 | Flat acetabular roof (HP:0003180) | 1.91568581 |
| 139 | Nephritis (HP:0000123) | 1.90344872 |
| 140 | Decreased circulating renin level (HP:0003351) | 1.90201534 |
| 141 | Premature loss of primary teeth (HP:0006323) | 1.89479172 |
| 142 | Hemorrhage of the eye (HP:0011885) | 1.89435236 |
| 143 | Spondylolisthesis (HP:0003302) | 1.88973640 |
| 144 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.88591623 |
| 145 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.88591623 |
| 146 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.88591623 |
| 147 | Gingival bleeding (HP:0000225) | 1.87633284 |
| 148 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.87096700 |
| 149 | Enlarged kidneys (HP:0000105) | 1.86616190 |
| 150 | Esophageal varix (HP:0002040) | 1.85623487 |
| 151 | Hypoplasia of dental enamel (HP:0006297) | 1.84848618 |
| 152 | Bone pain (HP:0002653) | 1.82469514 |
| 153 | Follicular hyperkeratosis (HP:0007502) | 1.81969874 |
| 154 | Subcapsular cataract (HP:0000523) | 1.81644233 |
| 155 | Hyperphosphatemia (HP:0002905) | 1.80421917 |
| 156 | Abnormal glucose tolerance (HP:0001952) | 1.80103242 |
| 157 | Widely patent fontanelles and sutures (HP:0004492) | 1.79975801 |
| 158 | Gingivitis (HP:0000230) | 1.79916198 |
| 159 | Abnormal cartilage morphology (HP:0002763) | 1.79529000 |
| 160 | Abnormality of renin-angiotensin system (HP:0000847) | 1.79260188 |
| 161 | Natal tooth (HP:0000695) | 1.76726915 |
| 162 | Generalized aminoaciduria (HP:0002909) | 1.75880943 |
| 163 | Hypophosphatemic rickets (HP:0004912) | 1.75557218 |
| 164 | Loss of speech (HP:0002371) | 1.75077191 |
| 165 | Thrombophlebitis (HP:0004418) | 1.74991892 |
| 166 | Hypophosphatemia (HP:0002148) | 1.74522516 |
| 167 | Emphysema (HP:0002097) | 1.74066643 |
| 168 | Ventricular tachycardia (HP:0004756) | 1.73614272 |
| 169 | Coxa vara (HP:0002812) | 1.73529573 |
| 170 | Distal lower limb muscle weakness (HP:0009053) | 1.72929209 |
| 171 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.72714269 |
| 172 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.72605861 |
| 173 | Stroke (HP:0001297) | 1.72373899 |
| 174 | Abnormality of iron homeostasis (HP:0011031) | 1.72314492 |
| 175 | Right ventricular cardiomyopathy (HP:0011663) | 1.71277725 |
| 176 | Status epilepticus (HP:0002133) | 1.69693669 |
| 177 | Hypotension (HP:0002615) | 1.69325108 |
| 178 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.66989847 |
| 179 | Advanced eruption of teeth (HP:0006288) | 1.66629890 |
| 180 | Ventricular fibrillation (HP:0001663) | 1.66135724 |
| 181 | Poikilocytosis (HP:0004447) | 1.65563426 |
| 182 | Abnormality of vitamin metabolism (HP:0100508) | 1.64516883 |
| 183 | Renal cortical cysts (HP:0000803) | 1.64008586 |
| 184 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.63186197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA2 | 6.23783374 |
| 2 | BCKDK | 5.88266680 |
| 3 | FGFR4 | 4.40842713 |
| 4 | ERN1 | 4.27778705 |
| 5 | SIK1 | 3.84420668 |
| 6 | MST1R | 3.05323741 |
| 7 | ERBB4 | 2.61401979 |
| 8 | TESK1 | 2.48826052 |
| 9 | MAP2K4 | 2.39073419 |
| 10 | MAPKAPK3 | 2.33523065 |
| 11 | EPHA3 | 2.19340379 |
| 12 | ACVR1B | 2.09814233 |
| 13 | PIK3CG | 2.05745914 |
| 14 | INSRR | 2.03926717 |
| 15 | TAOK3 | 1.94462840 |
| 16 | MYLK | 1.94309247 |
| 17 | DDR2 | 1.80241105 |
| 18 | NEK9 | 1.67681618 |
| 19 | LATS1 | 1.66390151 |
| 20 | PRKG2 | 1.60699097 |
| 21 | TRIB3 | 1.57826317 |
| 22 | CDC42BPA | 1.54963522 |
| 23 | STK24 | 1.51538806 |
| 24 | MAPK11 | 1.49026622 |
| 25 | FGFR2 | 1.47394315 |
| 26 | FRK | 1.46043088 |
| 27 | FER | 1.42525051 |
| 28 | DAPK2 | 1.42393665 |
| 29 | MAP3K3 | 1.35421641 |
| 30 | PTK6 | 1.34953918 |
| 31 | PKN2 | 1.33632168 |
| 32 | MAPKAPK5 | 1.32646704 |
| 33 | ABL2 | 1.30587156 |
| 34 | TGFBR2 | 1.29199487 |
| 35 | TYK2 | 1.28402407 |
| 36 | FLT3 | 1.28222427 |
| 37 | LATS2 | 1.27662867 |
| 38 | MAP3K2 | 1.21176183 |
| 39 | MAP3K6 | 1.19133161 |
| 40 | MAP3K7 | 1.16722225 |
| 41 | PINK1 | 1.15942003 |
| 42 | NTRK1 | 1.15046167 |
| 43 | MET | 1.12163060 |
| 44 | PAK4 | 1.09917168 |
| 45 | MAP3K11 | 1.09421713 |
| 46 | EPHB1 | 1.02573453 |
| 47 | RET | 1.02080073 |
| 48 | FGFR3 | 1.01766025 |
| 49 | JAK2 | 1.01711330 |
| 50 | MAPK4 | 1.00179291 |
| 51 | MAP3K14 | 0.99719399 |
| 52 | EPHB2 | 0.96218282 |
| 53 | MAP2K3 | 0.94077712 |
| 54 | DMPK | 0.92483813 |
| 55 | STK38L | 0.92346420 |
| 56 | ERBB2 | 0.89638800 |
| 57 | ZAP70 | 0.88636995 |
| 58 | CAMK2G | 0.87086455 |
| 59 | BMX | 0.86889374 |
| 60 | MAP2K1 | 0.86239085 |
| 61 | GRK5 | 0.86087626 |
| 62 | KSR2 | 0.85715970 |
| 63 | TBK1 | 0.85034433 |
| 64 | NME2 | 0.83898353 |
| 65 | TAOK1 | 0.83417020 |
| 66 | JAK1 | 0.81348307 |
| 67 | MAP3K12 | 0.80948107 |
| 68 | MAPK12 | 0.80740724 |
| 69 | MAP2K6 | 0.79067476 |
| 70 | PRKCZ | 0.78291691 |
| 71 | PRKACG | 0.77044702 |
| 72 | PRKAA2 | 0.76058715 |
| 73 | PTK2 | 0.73849319 |
| 74 | PIK3CA | 0.73611877 |
| 75 | MAP3K1 | 0.73284075 |
| 76 | PDGFRB | 0.72802086 |
| 77 | CDK6 | 0.71332784 |
| 78 | DYRK1B | 0.70668918 |
| 79 | PAK3 | 0.70619489 |
| 80 | CSK | 0.70474879 |
| 81 | TTN | 0.69815386 |
| 82 | ICK | 0.68235620 |
| 83 | STK39 | 0.67076627 |
| 84 | KDR | 0.65309885 |
| 85 | IRAK3 | 0.63741647 |
| 86 | SMG1 | 0.62685018 |
| 87 | KIT | 0.58343058 |
| 88 | JAK3 | 0.58193242 |
| 89 | STK38 | 0.57170611 |
| 90 | SGK2 | 0.55099062 |
| 91 | SGK3 | 0.52807755 |
| 92 | HIPK2 | 0.52586372 |
| 93 | NLK | 0.51897069 |
| 94 | GSK3A | 0.49701300 |
| 95 | GRK1 | 0.48972903 |
| 96 | MAPK15 | 0.48425770 |
| 97 | NEK6 | 0.48297890 |
| 98 | RIPK1 | 0.46752633 |
| 99 | RPS6KA2 | 0.45997518 |
| 100 | GRK6 | 0.45001331 |
| 101 | MAP2K2 | 0.44864306 |
| 102 | PRPF4B | 0.44438967 |
| 103 | SIK3 | 0.44216720 |
| 104 | MAP3K5 | 0.42985236 |
| 105 | IGF1R | 0.42883810 |
| 106 | MAPKAPK2 | 0.42347250 |
| 107 | SRC | 0.41759561 |
| 108 | PIM2 | 0.41234841 |
| 109 | TRPM7 | 0.40459477 |
| 110 | PRKCQ | 0.40436697 |
| 111 | BLK | 0.40114476 |
| 112 | PRKCG | 0.39163821 |
| 113 | SGK223 | 0.39113505 |
| 114 | SGK494 | 0.39113505 |
| 115 | LMTK2 | 0.38901854 |
| 116 | STK3 | 0.38497844 |
| 117 | BMPR2 | 0.38090196 |
| 118 | ARAF | 0.37971927 |
| 119 | IRAK1 | 0.37487316 |
| 120 | PDPK1 | 0.37158588 |
| 121 | PRKAA1 | 0.36216898 |
| 122 | CAMK2D | 0.35605531 |
| 123 | PRKCI | 0.32882220 |
| 124 | TIE1 | 0.32847859 |
| 125 | CAMK1D | 0.32511135 |
| 126 | MAP3K9 | 0.32210842 |
| 127 | PDGFRA | 0.32184624 |
| 128 | IRAK4 | 0.31173024 |
| 129 | IKBKB | 0.30999546 |
| 130 | MAPK7 | 0.29908666 |
| 131 | MAP3K10 | 0.29620301 |
| 132 | PRKCA | 0.29183377 |
| 133 | PRKCD | 0.28871475 |
| 134 | RPS6KL1 | 0.28653569 |
| 135 | RPS6KC1 | 0.28653569 |
| 136 | PRKD2 | 0.27657147 |
| 137 | BCR | 0.26576933 |
| 138 | PRKACA | 0.26335883 |
| 139 | MATK | 0.26061224 |
| 140 | ROCK1 | 0.25551041 |
| 141 | EGFR | 0.23649117 |
| 142 | CSNK1G1 | 0.22791392 |
| 143 | LRRK2 | 0.22781661 |
| 144 | MST4 | 0.22673429 |
| 145 | FGFR1 | 0.22025417 |
| 146 | IKBKE | 0.21650893 |
| 147 | PKN1 | 0.21030734 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.68748847 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.29919023 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.27406819 |
| 4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.18418427 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.93945871 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.76609493 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.74897324 |
| 8 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.64336489 |
| 9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55955006 |
| 10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.53264417 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.38274796 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36698294 |
| 13 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.16116756 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.13041577 |
| 15 | Peroxisome_Homo sapiens_hsa04146 | 2.11166171 |
| 16 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08665769 |
| 17 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 2.05168545 |
| 18 | Histidine metabolism_Homo sapiens_hsa00340 | 2.01735568 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.97193736 |
| 20 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.95888669 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.94142765 |
| 22 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.90254709 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.89759480 |
| 24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86967382 |
| 25 | Asthma_Homo sapiens_hsa05310 | 1.80400970 |
| 26 | Retinol metabolism_Homo sapiens_hsa00830 | 1.79080462 |
| 27 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70793321 |
| 28 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.69983945 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.69882534 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.66410232 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.65546825 |
| 32 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.65439398 |
| 33 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.65201680 |
| 34 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.64429821 |
| 35 | Other glycan degradation_Homo sapiens_hsa00511 | 1.59019505 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.57700452 |
| 37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57180199 |
| 38 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.55061310 |
| 39 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.49891467 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.44740111 |
| 41 | Allograft rejection_Homo sapiens_hsa05330 | 1.41099815 |
| 42 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.38572116 |
| 43 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.36297825 |
| 44 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.34299140 |
| 45 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.34091664 |
| 46 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.33142676 |
| 47 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.31737342 |
| 48 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.30077782 |
| 49 | ABC transporters_Homo sapiens_hsa02010 | 1.27322808 |
| 50 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.26720859 |
| 51 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.26108516 |
| 52 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.24494396 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22534420 |
| 54 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.21230438 |
| 55 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.14916707 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.13438757 |
| 57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11403209 |
| 58 | Leishmaniasis_Homo sapiens_hsa05140 | 1.11181738 |
| 59 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.08556253 |
| 60 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04985937 |
| 61 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04497923 |
| 62 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.01577009 |
| 63 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.01481645 |
| 64 | Lysosome_Homo sapiens_hsa04142 | 0.99416766 |
| 65 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96481706 |
| 66 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.95451239 |
| 67 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94431258 |
| 68 | Sulfur relay system_Homo sapiens_hsa04122 | 0.91240374 |
| 69 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.89691037 |
| 70 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.88107129 |
| 71 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.86316192 |
| 72 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.85917247 |
| 73 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.83069723 |
| 74 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82420120 |
| 75 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.82321127 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81761091 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.80498366 |
| 78 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.79999860 |
| 79 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.79174382 |
| 80 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.79045872 |
| 81 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77002956 |
| 82 | Viral myocarditis_Homo sapiens_hsa05416 | 0.76400237 |
| 83 | Tuberculosis_Homo sapiens_hsa05152 | 0.74935070 |
| 84 | Salmonella infection_Homo sapiens_hsa05132 | 0.73737935 |
| 85 | Tight junction_Homo sapiens_hsa04530 | 0.72928767 |
| 86 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72436590 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.69225714 |
| 88 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68900773 |
| 89 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67045377 |
| 90 | Lysine degradation_Homo sapiens_hsa00310 | 0.66470419 |
| 91 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66287782 |
| 92 | Influenza A_Homo sapiens_hsa05164 | 0.64901122 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.57455706 |
| 94 | Renin secretion_Homo sapiens_hsa04924 | 0.55938777 |
| 95 | Phagosome_Homo sapiens_hsa04145 | 0.54630750 |
| 96 | Focal adhesion_Homo sapiens_hsa04510 | 0.52877889 |
| 97 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52289089 |
| 98 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.52219121 |
| 99 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.49085256 |
| 100 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.49062122 |
| 101 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.47469308 |
| 102 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.47019024 |
| 103 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.45732894 |
| 104 | Metabolic pathways_Homo sapiens_hsa01100 | 0.45201653 |
| 105 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.44822581 |
| 106 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.43791519 |
| 107 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.43694228 |
| 108 | Prion diseases_Homo sapiens_hsa05020 | 0.43683811 |
| 109 | Adherens junction_Homo sapiens_hsa04520 | 0.43468796 |
| 110 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.42283192 |
| 111 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.41325781 |
| 112 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.39902401 |
| 113 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.38805954 |
| 114 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.36986779 |
| 115 | Malaria_Homo sapiens_hsa05144 | 0.36803321 |
| 116 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.36332912 |
| 117 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.34196588 |
| 118 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.33133325 |
| 119 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.27049197 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.24820028 |
| 121 | Insulin resistance_Homo sapiens_hsa04931 | 0.24219849 |
| 122 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.23777555 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18033504 |
| 124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.09874354 |
| 125 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03625303 |
| 126 | Pertussis_Homo sapiens_hsa05133 | -0.2355712 |
| 127 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.2043928 |
| 128 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.1906562 |
| 129 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | -0.1837856 |
| 130 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.1824491 |
| 131 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1652188 |
| 132 | Amoebiasis_Homo sapiens_hsa05146 | -0.1593849 |
| 133 | Hepatitis C_Homo sapiens_hsa05160 | -0.1511359 |
| 134 | Mineral absorption_Homo sapiens_hsa04978 | -0.1480449 |
| 135 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1442242 |
| 136 | Bladder cancer_Homo sapiens_hsa05219 | -0.1221598 |
| 137 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1201618 |
| 138 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.0960569 |
| 139 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0875495 |
| 140 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0557990 |
| 141 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.0486370 |
| 142 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0443419 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.0323472 |
| 144 | AMPK signaling pathway_Homo sapiens_hsa04152 | -0.0186922 |
| 145 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.0153774 |
| 146 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0146924 |

